Ignite Creation Date:
2025-12-25 @ 1:17 AM
Ignite Modification Date:
2025-12-25 @ 11:26 PM
Study NCT ID:
NCT06668493
Status:
RECRUITING
Last Update Posted:
2025-11-26
First Post:
2024-10-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
Sponsor:
Ferring Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
000425
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None